X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (16) 16
female (10) 10
humans (10) 10
oncology (10) 10
breast cancer (9) 9
middle aged (7) 7
aged (6) 6
breast neoplasms - drug therapy (6) 6
chemotherapy (6) 6
health aspects (6) 6
adult (5) 5
breast neoplasms - pathology (4) 4
cancer (4) 4
patients (4) 4
receptor, erbb-2 - metabolism (4) 4
studies (4) 4
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer therapies (3) 3
clinical trials (3) 3
drug resistance (3) 3
follow-up studies (3) 3
male (3) 3
medicine & public health (3) 3
metastasis (3) 3
original (3) 3
research (3) 3
analysis (2) 2
antimicrobial agents (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
atrophy (2) 2
biography (2) 2
biomarkers (2) 2
biotechnology (2) 2
breast neoplasms (2) 2
breast neoplasms - genetics (2) 2
breast neoplasms - metabolism (2) 2
cachexia (2) 2
cancer patients (2) 2
care and treatment (2) 2
chemotherapy, adjuvant (2) 2
cross-sectional studies (2) 2
dictionaries (2) 2
disease-free survival (2) 2
double-blind method (2) 2
drug therapy (2) 2
dyspnea (2) 2
endocrine therapy (2) 2
estrogen (2) 2
gene sequencing (2) 2
genes (2) 2
genomes (2) 2
health care (2) 2
incidence (2) 2
kaplan-meier estimate (2) 2
lung cancer (2) 2
medical research (2) 2
medicine (2) 2
neoplasm staging (2) 2
nuclear magnetic resonance--nmr (2) 2
open-label (2) 2
original article (2) 2
patient outcomes (2) 2
public health (2) 2
randomized controlled trial (2) 2
research article (2) 2
risk (2) 2
scanning electron microscope (2) 2
science (2) 2
survival analysis (2) 2
trastuzumab (2) 2
trastuzumab - administration & dosage (2) 2
trastuzumab - adverse effects (2) 2
treatment outcome (2) 2
usage (2) 2
women (2) 2
young adult (2) 2
1506 (1) 1
1717 (1) 1
1761-1824 (1) 1
1788-1851 (1) 1
1st-line treatment (1) 1
2nd-line treatment (1) 1
396 (1) 1
611 (1) 1
929:50 (1) 1
a survey (1) 1
abemaciclib (1) 1
abridged index medicus (1) 1
abstracts (1) 1
academic medical centers (1) 1
acids (1) 1
activating-factor acetylhydrolase (1) 1
acute coronary syndrome (1) 1
acute coronary syndrome - drug therapy (1) 1
acute coronary syndromes (1) 1
adjuvant (1) 1
administration, oral (1) 1
adolescent (1) 1
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Knox College (Caven) - Stacks (1) 1
Music - Protected Material (1) 1
Music - Stacks (1) 1
Online Resources - Online (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Oncologist, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. e643 - e645
Technology has changed the way medicine is practiced. This commentary considers the effect of digital communications and offers advice on e‐mail etiquette. 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26_suppl, pp. 111 - 111
Journal Article
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
ONCOLOGIST, ISSN 1083-7159, 08/2019, Volume 24, Issue 8, pp. E643 - E645
Technology has changed the way medicine is practiced. This commentary considers the effect of digital communications and offers advice on e-mail etiquette. 
ONCOLOGY
Journal Article
Oncologist, ISSN 1083-7159, 2019, p. theoncologist.2019-0019
PALOMA-2 confirmed that first-line palbociclib + letrozole improved progression-free survival (hazard ratio, 0.58; 95% confidence interval, 0.46-0.72) in... 
Hematologic | Breast cancer | Safety | Palbociclib | Neutropenia
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 8/2019, Volume 177, Issue 1, pp. 93 - 101
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. 10109 - 10109
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 4/2019, Volume 27, Issue 4, pp. 1551 - 1561
Journal Article
BMC Medical Informatics and Decision Making, ISSN 1472-6947, 12/2019, Volume 19, Issue 1, pp. 1 - 16
Premenopausal breast cancer patients are at risk of treatment-related infertility. Many patients do not receive sufficient fertility information before... 
Care and treatment | Cancer patients | Breast cancer | Health aspects | Menopause | Decision-making | Decision aid | Fertility preservation | Alpha testing | Oncofertility
Journal Article
The Oncologist, ISSN 1083-7159, 02/2017, Volume 22, Issue 2, pp. 236 - 240
Physicians and academic researchers are frequently targeted with spam invitations to submit manuscripts to predatory journals. This study was conducted to... 
ONCOLOGY | Electronic Mail - statistics & numerical data | Journalism, Medical | Publishing | Academic Medical Centers | Humans | Brief Communications
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 3_suppl, pp. 179 - 179
Journal Article
Journal of Cachexia, Sarcopenia and Muscle, ISSN 2190-5991, 10/2019, Volume 10, Issue 5, pp. 1070 - 1082
Background Cancer is a systemic catabolic condition affecting skeletal muscle and fat. We aimed to determine whether cardiac atrophy occurs in this condition... 
Cachexia | Left ventricular mass | Cardiac atrophy | Cancer | Hypertension | Medical research | Nuclear magnetic resonance--NMR | Lung cancer | Patients | Cancer therapies | Atrophy | Musculoskeletal system | Chemotherapy | Dyspnea | Cardiac function | Biomarkers | Longitudinal studies | Original
Journal Article
BMJ Open, ISSN 2044-6055, 09/2019, Volume 9, Issue 9, p. e029975
IntroductionCancer care has expanded from a disease-focused, survival-oriented model to an approach that now considers how survivors can live well in the... 
Studies | Health care | Physical fitness | Cancer therapies
Journal Article
The Oncologist, ISSN 1083-7159, 03/2017, Volume 22, Issue 3, pp. 245 - 254
Background Icrucumab (ICR) and ramucirumab (RAM) bind vascular endothelial growth factor (VEGF) receptors 1 and 2 (VEGFR‐1 and ‐2), respectively. This... 
Monoclonal antibodies | Breast cancer | Metastasis | Drug resistance | Capecitabine | 1ST-LINE TREATMENT | BEVACIZUMAB | MONOCLONAL-ANTIBODY | FACTOR RECEPTOR-2 | OPEN-LABEL | TUMOR ANGIOGENESIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | 2ND-LINE TREATMENT | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Capecitabine - administration & dosage | Vascular Endothelial Growth Factor Receptor-1 - antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | Drug-Related Side Effects and Adverse Reactions - pathology | Neovascularization, Pathologic - pathology | Vascular Endothelial Growth Factor Receptor-2 - genetics | Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Adult | Female | Vascular Endothelial Growth Factor Receptor-1 - genetics | Breast Neoplasms - drug therapy | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Breast Neoplasms - genetics | Capecitabine - adverse effects | Antibodies, Monoclonal - administration & dosage | Breast Neoplasms - pathology | Neovascularization, Pathologic - drug therapy | Neovascularization, Pathologic - genetics | Aged | Breast Cancer
Journal Article